DOCSLIB.ORG

Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion lR;eso t;rs lR;eso t;rs Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion Ministry of Health & Family Welfare Government of India JANUARY 2016 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion iii Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion v Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion vii Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion ix Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion xi List of Acronyms AIDS Acquired Immunodeficiency Syndrome ANM Auxiliary Nurse Midwife ACOG American Congress of Obstetricians and Gynaecologists BP Blood Pressure CAC Comprehensive Abortion Care Gm Gram HIV Human Immunodeficiency Virus IEC Information Education Communication IUCD Intrauterine Contraceptive Device IV Intravenous PC-PNDT Pre Conception and Pre Natal Diagnostic Techniques LMP Last Menstrual Period MTP Medical Termination of Pregnancy MMA Medical Methods of Abortion Mcg Microgram NHM National Health Mission POC Products of Conception P/S Per Speculum P/V Per Vaginum Rh Rhesus (Blood group) USG Ultra Sonography VA Vacuum Aspiration SRS Sample Registration System LSCS Lower Segment Caesarean Section OPD Out Patient Department WHO World Health Organization RMP Registered Medical Practitioner Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion xiii List of Contributors 1. Shri C. K. Mishra Additional Secretary & Mission Director (NHM), MoHFW 2. Dr Rakesh Kumar Joint Secretary (RMNCH+A), MoHFW 3. Dr Dinesh Baswal Deputy Commissioner (Incharge Maternal Health), MoHFW 4. Dr Veena Dhawan Assistant Commissioner ( Maternal Health ), MoHFW 5. Professor Suneeta Mittal Director & Head, Department of Obstetrics & Gynaecology, Fortis Memorial Research Institute 6. Dr. Bela Ganatra Scientist, Department of Reproductive Health & Research, World Health Organization, Geneva 7. Dr. Pratima Mittal Professor & Head, Department of Obstetrics & Gynaecology, VMMC & Safdarjung Hospital, New-Delhi 8. Dr. Poonam Varma Shiv Professor & Head, Department of Obstetrics & Gynaecology, Kumar MGIMS, Sewagram, Maharashtra 9. Dr. Vidushi Kulshrestha Assistant Professor Department of Obstetrics & Gynaecology,, AIIMS, New Delhi 10. Dr. Vinita Das Professor & Head, Department of Obstetrics & Gynaecology, King George’s Medical University, Lucknow, Uttar Pradesh 11. Dr. Sudha Prasad Professor & Head, Department of Obstetrics & Gynaecology, Maulana Azad Medical College & Hospital, New-Delhi 12. Dr. Abha Singh Director Professor, Department of Obstetrics & Gynaecology, Lady Harding Medical College, New Delhi 13. Dr. Sudha Salhan Professor, Department of Obstetrics & Gynaecology NDMC Medical College and Hindu Rao Hospital, New Delhi 14. Dr. Sangeeta Batra Senior Director (Health Systems), Ipas Development Foundation 15. Dr Pushkar Kumar Lead Consultant, Maternal Health, MoHFW 16. Dr Rajeev Agrawal Senior Management Consultant, Maternal Health, MoHFW 17. Dr. Tarun Singh Sodha Consultant (Maternal Health), MoHFW 18. Ms. Jenita Khwairakpam Consultant (Maternal Health), MoHFW 19. Dr. Ashish Banerjee Consultant (Maternal Health), MoHFW 20. Dr. Salima Bhatia Senior Consultant (Maternal Health), MoHFW Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion xv Contents Message ............................................................................................................................................... iii Foreword .............................................................................................................................................. v Preface ................................................................................................................................................vii Acknowledgement ............................................................................................................................ ix About the Handbook ........................................................................................................................ xi List of Acronyms ............................................................................................................................. xiii List of Contributors .......................................................................................................................... xv Introduction to Medical Methods of Abortion (MMA) .................................................................1 Section 1: Medical Methods of Abortion - An Overview ..................................................................2 1.1: Advantages and Limitations of MMA ......................................................................................2 Section 2: Law (MTP Act) and MMA ....................................................................................................3 2.1: Eligibility of the Provider ............................................................................................................3 2.2: Eligibility of the Place ..................................................................................................................3 2.3: Documentation of MMA Procedure ..........................................................................................4 Section 3: Indications/Contraindications for MMA ...........................................................................5 3.1: Indications for MMA ...................................................................................................................5 3.2: Contraindications for MMA .......................................................................................................5 3.3: Special Precautions for MMA .....................................................................................................6 Section 4: MMA Drugs .............................................................................................................................7 4.1: Drugs used in MMA ....................................................................................................................7 Section 5: MMA Protocol and Process ................................................................................................10 5.1: Drug Protocol ..............................................................................................................................10 5.2: Process of MMA..........................................................................................................................10 5.3: Post MMA Contraception .........................................................................................................18 Section 6: Side Effects and Complications with MMA ...................................................................19 6.1: Side Effects and their Treatment ..............................................................................................19 6.2: Complications and their Management ....................................................................................20 6.3. Warning Symptoms and Signs .................................................................................................22 Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion xvii Section 7: Safety and Effectiveness .....................................................................................................23 Section 8: Comparison: VA and MMA Procedure ............................................................................24 Section 9: Suggested Agenda for MMA Reorientation ...................................................................26 References .................................................................................................................................................27 Annexures Annexure 1: Medical Methods of Abortion Skills Checklist .............................................................28 Annexure 2: Essential Equipment and Supplies for MMA ................................................................31 Annexure 3: MMA: Documentation Formats ......................................................................................32 Annexure 4: MMA Follow-up Card ......................................................................................................36 Annexure 5: Medical Methods of Abortion (MMA) Reorientation Pre and Post-training Assessment ..............................................................................................37 xviii Handbook on Medical Methods of Abortion to Expand Access to New Technologies for Safe Abortion Introduction to Medical Methods of Abortion (MMA) Unsafe abortions make a significant contribution to maternal morbidity and mortality. As per SRS 2001-03, abortion-related deaths account for nearly eight per cent of all maternal deaths in India, which translates to about 3,520 deaths annually. Numerous barriers limit access to safe abortion services including shortage of trained providers; lack of infrastructure at the facilities; and lack of information about legality and availability of services among women and the community. Medical Methods of Abortion is one of the safe technologies for abortion care which offers an opportunity to increase access to abortion care services especially in early pregnancy. It can be offered at all
Load more

Recommended publications
  • Medical Abortion: an Update
    Foreword The continued demand for abortion services refl ects the unmet need for avoiding unwanted pregnancies. Unsafe abortions have always been a hazard to the lives of women. The fact that safe abortions save lives has been proven time and again across all cultures and countries. The provision of safe abortion services therefore assumes an importance which extends beyond simply doing the MTP. Despite the availability of medication abortion since 2002 there is a felt need to disseminate the optimal uses of this safe and eff ective technology. Most providers fail to use this technology because of fears which are not necessarily grounded in facts. It is 1 hoped that publications like these as this will dispel such fears. FOGSI remains committed to making abortions safer and this commitment is refl ected in the support of the offi ce bearers and past chairperson of the MTP committee in making this publication a reality. Many thanks to Dr. C.N. Purandare, Dr. Sanjay Gupte, Dr. Shirish Patwardhan, Dr. P.K. Shah, Dr. Nozer Sherier, Dr. Hrishikesh Pai. We are grateful to Cipla for supporting this initiative. Dr. Kiran Kurtkoti Dr. Jaydeep Tank Chairperson-MTP Committee, FOGSI Immediate Past Chairperson MTP Committee 2 Medical Abortion: An Update Introduction Evolution of Medical Abortion Unsafe abortion is still a major health problem in the world. Of Inducing abortion by administering drugs is not a new the 6.4 million abortions performed in India in 2002 and 2003, concept. Historic documents list an incredibly large number of 56% or 3.6 million were unsafe (Abortion Assessment Project drugs, tablets, decoctions and other substances like papaya , 3 I, 2004).
    [Show full text]
  • Medical Abortion Reference Guide INDUCED ABORTION and POSTABORTION CARE at OR AFTER 13 WEEKS GESTATION (‘SECOND TRIMESTER’) © 2017, 2018 Ipas
    Medical Abortion Reference Guide INDUCED ABORTION AND POSTABORTION CARE AT OR AFTER 13 WEEKS GESTATION (‘SECOND TRIMESTER’) © 2017, 2018 Ipas ISBN: 1-933095-97-0 Citation: Edelman, A. & Mark, A. (2018). Medical Abortion Reference Guide: Induced abortion and postabortion care at or after 13 weeks gestation (‘second trimester’). Chapel Hill, NC: Ipas. Ipas works globally so that women and girls have improved sexual and reproductive health and rights through enhanced access to and use of safe abortion and contraceptive care. We believe in a world where every woman and girl has the right and ability to determine her own sexuality and reproductive health. Ipas is a registered 501(c)(3) nonprofit organization. All contributions to Ipas are tax deductible to the full extent allowed by law. For more information or to donate to Ipas: Ipas P.O. Box 9990 Chapel Hill, NC 27515 USA 1-919-967-7052 [email protected] www.ipas.org Cover photo: © Ipas The photographs used in this publication are for illustrative purposes only; they do not imply any particular attitudes, behaviors, or actions on the part of any person who appears in the photographs. Printed on recycled paper. Medical Abortion Reference Guide INDUCED ABORTION AND POSTABORTION CARE AT OR AFTER 13 WEEKS GESTATION (‘SECOND TRIMESTER’) Alison Edelman Senior Clinical Consultant, Ipas Professor, OB/GYN Oregon Health & Science University Alice Mark Associate Medical Director National Abortion Federation About Ipas Ipas works globally so that women and girls have improved sexual and reproductive health and rights through enhanced access to and use of safe abortion and contraceptive care.
    [Show full text]
  • Abortion by Rape Victim: a Dilemma in the Drat of Penal Code and Indonesian Health Law
    Journal of Law and Legal Reform JOURNAL (2020 OF), 1 (LAW4), pp. & 631 LEGAL-640. REFORM VOLUME 1(4) 2020 631 DOI: https://doi.org/10.15294/jllr.v1i4.39659 ISSN (Print) 2715-0941, ISSN (Online) 2715-0968 RESEARCH ARTICLE ABORTION BY RAPE VICTIM: A DILEMMA IN THE DRAT OF PENAL CODE AND INDONESIAN HEALTH LAW Fikri Ariyad1, Ali Masyhar2 1 LBH Rumah Pejuang Keadilan Kota Semarang, Indonesia 2 Faculty of Law, Universitas Negeri Semarang, Indonesia [email protected] CITED AS Ariyad, F., & Masyhar, A. (2020). Abortion by Rape Victim: A Dilemma in the Drat of Penal Code and Indonesian Health Law. Journal of Law and Legal Reform, 1(4), 631-640. https://doi.org/10.15294/jllr.v1i4.39659 ABSTRACT In this present time, the debate about abortion in Indonesia is increasingly crowded. Abortion is also carried out by women - victims of rape to reduce the burden they suffered. The regulation on abortion in Indonesia has been regulated in the statutory regulations, namely the Criminal Code, especially in Article 346, Article 347, Article 348, and Article 349. In the RKUHP (Draft of Criminal Code), abortion regulation is regulated in two chapters namely, Chapter XIV Article 501 and Chapter XIX Articles 589, 590, 591, 592. In addition, the government has also issued several regulations governing abortion such as Government Regulation No. 61 of 2014 concerning Reproductive Health and also Law No. 36 of 2009 concerning health. However, the various regulations that exist between the Criminal Code, RKUHP, PP and the Act actually contradict to each other. There is no synchronization between the regulations regarding abortion by women rape victims.
    [Show full text]
  • Abortion Policy Landscape-India2
    First Second Post-Abortion Trimester Trimester Care Specialists (ob gyns) WHO Non-specialists (general physicians) Medical abortion ** *** (using mifepristone (Up to 9 weeks) & misoprostol combination) Surgical abortion HOW (vacuum aspiration) Surgical abortion (dilatation & evacuation) All public-sector Secondary and tertiary public- Where facilities and All public and approved private sector facilities private sector facilities/ and approved facilities clinics**** private facilities *Qualiication and training criteria apply. **The Drug Controller General of India limits the use of MA drugs upto nine weeks. However, the national CAC guidelines10 include drug protocol for second trimester abortions in accordance with WHO Guidelines 2014, for reference. *** Misoprostol only. **** MA upto seven weeks can also be prescribed from an outpatient clinic with an established referral access to MTP-approved facility. REFERENCES 1 United Nations, Department of Economic and Social Aairs, Population Division (2019). World Population Prospects 2019, Online Edition. Rev. 1 https://population.un.org/wpp/Download/Standard/Population/ 2 Census of India 2011 http://www.censusindia.gov.in/2011census/population_enumeration.html 3 Sample Registration System 201416 http://www.censusindia.gov.in/vital_statistics/ SRS_Bulletins/MMR%20Bulletin-201416.pdf 4 National Family Health Survey 4 (201516) http://rchiips.org/nhs/pdf/NFHS4/India.pdf 5 Maternal Mortality Ratio: India, EAG & Assam, Southern States and Other States https://www.niti.gov.in/content/maternal-mortality-ratio-mmr-100000-live-births ABORTION 6 National Family Health Survey 1 (199293) http://rchiips.org/nhs/india1.shtml 7 Sample Registration Survey. Maternal Mortality in India: 19972003. Trends, Causes and Risk Factors. Registrar General. India http://www.cghr.org/wordpress/wp-content/uploads/RGICGHRMaternal-Mortality-in- India-1997%E2%80%932003.pdf POLICY LANDSCAPE 8 Banerjee et al.
    [Show full text]
  • Salud. Acceso. Derechos. Concepcion Beistegui 106 1 Col
    Salud. Acceso. Derechos. Concepcion Beistegui 106 1 Col. del Valle 1 03100, Mexico D.F. Tel: +52 (55) 11 07 69 69 1 Fax: +52 (55) 11 07 69 84 [email protected] 1 www.ipas.org Members of the CEDAW Committee Office of the United Nations High Commissioner for Human Rights Palais Wilson 52 me des Páquis CH-1201 Geneva, Switzerland RE: List of Issues to the Committee on the Elimination of Discrimination against Women (CEDAW), Pre-Sessional Working Group, 70th session, 2017. State party: Mexico Dear Committee Members: Ipas is an organization that works around the world to increase women's ability to exercise their sexual and reproductive rights.1 Our aim with this letter is to provide questions to be asked to the Mexican state to comply with its international human rights obligations and protect women's human right to health established in Article 12 and right to equality and non-discrimination established in Article 16(1) (e) from the Convention on the Elirnination of Al! Forms of Discrimination against Women (CEDAW). Unsafe abortion: major public health and human rights issue Worldwide, 25 million unsafe abortions occurred every year between 2010 and 2014. The majority (97%) of these abortions, occurred in developing countries in Africa, Asia and Latin America.2 The World Health Organization has found that high rates of maternal mortality and morbidity are correlated with restrictive abortion laws.3 Nearly 25% of the world's women live where abortion is prohibited except on the grounds of rape, incest or to save a woman's life.
    [Show full text]
  • Sex-Selective Abortion in India: Exploring Institutional Dynamics and Responses
    McGill Sociological Review, Volume 3 (February 2013): 18–35 Sex-selective Abortion in India: Exploring Institutional Dynamics and Responses Sugandha Nagpal York University, Toronto In India, sex-selective abortion is an established phenomenon that cuts across ru- ral/urban, educational and socioeconomic status divides. However, in understand- ing this complex and deeply contextualized issue, kinship patterns, dowry and the low social value accorded to women are often mobilized to serve as overarching explanations. While these factors are important in explaining sex-selection, in an effort to expand beyond the generalizing discourse that exercises a single point fo- cus on patriarchal cultural practices, this paper centralizes the role of institutional structures. Specifically, the paper explores state population control policies and the unchecked utilization of reproductive technologies to uncover the contemporary institutional factors that lend sex-selective abortion a normative appeal. Moreover, legal approaches to eradicating sex-selective abortion are examined in tandem with feminist conceptualizations of the issue to uncover the efficacy and dynamics of in- stitutional responses to sex- selection in India. The paper asserts the importance of an integrative approach for understanding and responding to sex-selection, both at the macro and micro level. The premature elimination of female foetuses is a widespread phenomenon in Asian coun- tries. In fact, Amartya Sen (2003) has uncovered that in the last century, “100 million women have been missing in South Asia due to "discrimination leading to death’ experi- enced by them from womb to tomb in their life cycles” (as cited in Patel 2007:289). For instance, in China in 2000 the child sex ratio at birth was 120 males per 100 females.
    [Show full text]
  • MEDICATION ABORTION Overview of Research & Policy in the United States
    MEDICATION ABORTION Overview of Research & Policy in the United States Liz Borkowski, MPH Julia Strasser, MPH Amy Allina, BA Susan Wood, PhD Bridging the Divide: A Project of the Jacobs Institute of Women’s Health December 2015 CONTENTS INTRODUCTION ................................................................................................................... 2 OVERVIEW OF MEDICATION ABORTION ...................................................................... 2 MECHANISM OF ACTION .............................................................................................................................. 2 SAFETY AND EFFICACY ................................................................................................................................. 4 FDA DRUG APPROVAL PROCESS ....................................................................................... 6 FDA APPROVAL OF MIFEPREX ................................................................................................................... 6 GAO REVIEW OF FDA APPROVAL PROCESS FOR MIFEPREX ................................................................ 8 MEDICATION ABORTION PROCESS: STATE OF THE EVIDENCE ............................ 9 FDA-APPROVED LABEL ............................................................................................................................... 9 EVIDENCE-BASED PROTOCOLS FOR MEDICATION ABORTION ........................................................... 10 Dosage .......................................................................................................................................................
    [Show full text]
  • Abortion Law in India: the Debate on Its Legality
    International Journal of Law International Journal of Law ISSN: 2455-2194 Impact Factor: RJIF 5.12 www.lawjournals.org Volume 4; Issue 2; March 2018; Page No. 272-276 Abortion law in India: The debate on its legality Punam Kumari Bhagat1, Pratish Sinha2 1 Assistant Professor, Department of Law, Law College Dehradun, Uttaranchal University, Dehradun, Uttarakhand, India 2 Research Scholar, Department of Law, Law College Dehradun, Uttaranchal University, Dehradun, Uttarakhand, India Abstract Despite 30 years of liberal legislation, the majority of women in India still lack access to safe abortion care. This paper critically reviews the history of abortion law and policy in India since the 1960s and research on abortion service delivery. Amendments in 2002 and 2003 to the 1971 Medical Termination of Pregnancy Act, including devolution of regulation of abortion services to the district level, punitive measures to deter provision of unsafe abortions, rationalisation of physical requirements for facilities to provide early abortion, and approval of medical abortion, have all aimed to expand safe services. Proposed amendments to the MTP Act to prevent sex-selective abortions would have been unethical and violated confidentiality, and were not taken forward. Continuing problems include poor regulation of both public and private sector services, a physician-only policy that excludes mid- level providers and low registration of rural compared to urban clinics; all restrict access. Poor awareness of the law, unnecessary spousal consent requirements, contraceptive targets linked to abortion, and informal and high fees also serve as barriers. Training more providers, simplifying registration procedures, de-linking clinic and provider approval, and linking policy with up-to-date technology, research and good clinical practice are some immediate measures needed to improve women’s access to safe abortion care.
    [Show full text]
  • Policy and Research Paper N°15 Introduction Background IUSSP
    Policy and Research Paper N°15 Abortion, Women's Health and Fertility David Anderson IUSSP ISBN 2-87108-066-6 © Copyright 1998 IUSSP Introduction Policy & Research Papers are primarily directed to policy makers at all levels. They should also be of interest to the educated public and to the academic community. The policy monographs give, in simple non-technical language, a synthetic overview of the main policy implications identified by the Committees and Working Groups. The contents are therefore strictly based on the papers and discussions of these seminars. For ease of reading no specific references to individual papers is given in the text. However the programme of the seminar and a listing of all the papers presented is given at the end of the monograph. This policy monograph is based on the seminar on 'Socio-Cultural and Political Aspects of Abortion in a Changing World' organized by the IUSSP Scientific Committee on Anthropological Demography and the Centre for Development Studies, Trivandrum, held in Trivandrum, India, from 25-28 March 1995. Background Today, worldwide, women may wish to interrupt a larger percentage of pregnancies than ever before. Throughout this century and especially since mid-century, women in nearly every country have been wishing to bear fewer and fewer children. As a result of these declining fertility desires and changing mores, the proportion of marital and extra-marital sexual activity in which children are unwanted or unacceptable has increased. Theoretically, modern contraceptive techniques, such as intrauterine devices, surgical sterilization and pharmaceuticals can prevent pregnancy in most instances. In actual practice, all except sterilization very commonly allow pregnancies to happen.
    [Show full text]
  • What Is Medical Abortion? Mifepristone Or Methotrexate, a Second Drug, Misoprostol, Is Taken
    Methotrexate is usually given to a pregnant woman in the form of an injection, or shot, although it also can be taken orally. It stops the ongoing implantation process that occurs during the first several weeks after conception. Misoprostol. Within a few days after taking either What Is Medical Abortion? mifepristone or methotrexate, a second drug, misoprostol, is taken. Misoprostol tablets (which may be placed either Definition into the vagina, between cheek and gum, or swallowed) A medical abortion is one that is brought about by taking cause the uterus to contract and empty. This ends the medications that will end a pregnancy. The alternative is pregnancy. surgical abortion, which ends a pregnancy by emptying the Mifepristone and methotrexate work in different ways, and uterus (or womb) with special instruments. Either of two so they will have slightly different effects on a woman's medications, mifepristone or methotrexate, can be used for body. A clinician can help a woman decide whether medical abortion. Each of these medications is taken medically induced abortion is the right option for her, and together with another medication, misoprostol, to induce which of the two drugs she should use. an abortion. How Long Do Medical Abortions Take? When Is Medical Abortion Used? It can take anywhere from about a day to 3-4 weeks from Before any abortion can be done, a medical professional the time a woman takes the first medication until the must confirm that a woman is indeed pregnant and medical abortion is completed. The length of time depends determine how long she has been pregnant.
    [Show full text]
  • Factors Affecting Sex-Selective Abortion in India and 17 Major States
    Factors Affecting Sex-Selective Abortion in India and 17 Major States Robert D Retherford and T K Roy National Family Health Survey Subject Reports Number 21 January 2003 International Institute for Population Sciences Mumbai, India East-West Center Program on Population Honolulu, Hawaii, USA Indias first and second National Family Health Surveys (NFHS-1 and NFHS-2) were conducted in 199293 and 199899 under the auspices of the Ministry of Health and Family Welfare- The surveys provide national and state-level estimates of fertility, infant and child mortality, family planning practice, maternal and child health, and the utilization of services available to mothers and children- The International Institute for Population Sciences, Mumbai, coordinated the surveys in cooperation with selected population research centres in India, the East-West Center in Honolulu, Hawaii, and ORC Macro in Calverton, Maryland- The United States Agency for International Development (USAID) provided funding for the surveys, and the United Nations Population Fund (UNFPA) provided support for the preparation and publication of this report- ISSN 1026-4736 This publication may be reproduced for educational purposes- Correspondence addresses: International Institute for Population Sciences Govandi Station Road, Deonar, Mumbai - 400 088, India Fax: 91-22-556-3257 E-mail: iipsnfhs@vsnl-com East-West Center, Population and Health Studies 1601 East-West Road, Honolulu, Hawaii 96848-1601, U-S-A- Fax: 1-808-944-7490 E-mail: poppubs@eastwestcenter-org Factors Affecting
    [Show full text]
  • Factors Affecting Sex-Selective Abortion in India
    NATIONALFAMILYHEALTHSURVEY B w U w L w L w E w T w I w N International Institute for Population Sciences Factors Affecting Sex-Selective East-West Center Population and Health Studies Abortion In India Number 17 irth histories collected during India’s first and second National Family Health January 2003 Surveys (NFHS-1 and NFHS-2) show an unusually large proportion of male ISSN 1083-8678 Bbirths in some population groups, which suggests that female fetuses are being aborted. Normally, about 105 boys are born for every 100 girls in a population, resulting in a sex ratio at birth of about 1.05. In India as a whole, the sex ratio at birth This NFHS Bulletin summarizes findings was 1.06 during 1978–92, the 15-year period covered by NFHS-1. It rose to 1.08 during from India’s first and second National 1984–98, the 15-year period covered by NFHS-2, but this is still not much higher than Family Health Surveys, conducted in the biological norm. 1992–93 and 1998–99, respectively, There is, however, considerable variation in the sex ratio at birth among certain under the auspices of the Indian Ministry population groups. The sex ratio at birth is particularly high in certain western and of Health and Family Welfare. The northern states, in families that have daughters but no sons, and among women with surveys provide national and state-level a high level of education and media exposure. In a few states, the sex ratio at birth is estimates of fertility, infant and child unusually low in families that have sons but no daughters, indicating some selective mortality, family planning practice, abortion of boys.
    [Show full text]